{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:01:35Z","timestamp":1778047295967,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12028-022-01556-6","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:02:10Z","timestamp":1657238530000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Higher Levels of Admission N-Terminal Pro-brain Natriuretic Peptide are Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"38","author":[{"given":"Guang-Dong","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMcp1605827","volume":"377","author":"MT Lawton","year":"2017","unstructured":"Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med. 2017;377:257\u201366.","journal-title":"N Engl J Med"},{"key":"1556_CR2","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke. 2012;43:1711\u201337.","journal-title":"Stroke"},{"key":"1556_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106064","volume":"30","author":"A Ikram","year":"2021","unstructured":"Ikram A, Javaid MA, Ortega-Gutierrez S, et al. Delayed cerebral ischemia after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2021;30: 106064.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1556_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12975-020-00867-0","volume":"12","author":"SN Neifert","year":"2021","unstructured":"Neifert SN, Chapman EK, Martini ML, et al. Aneurysmal subarachnoid hemorrhage: the last decade. Transl Stroke Res. 2021;12:428\u201346.","journal-title":"Transl Stroke Res"},{"key":"1556_CR5","first-page":"21","volume":"59","author":"JA Frontera","year":"2006","unstructured":"Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21\u20137 (discussion 21\u20137).","journal-title":"Neurosurgery"},{"key":"1556_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12028-020-01142-8","volume":"35","author":"C Melinosky","year":"2021","unstructured":"Melinosky C, Kincaid H, Claassen J, et al. The modified Fisher scale lacks interrater reliability. Neurocrit Care. 2021;35:72\u20138.","journal-title":"Neurocrit Care"},{"key":"1556_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1212\/WNL.0000000000000057","volume":"82","author":"I van der Bilt","year":"2014","unstructured":"van der Bilt I, Hasan D, van den Brink R, et al. Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: relationship with outcome. Neurology. 2014;82:351\u20138.","journal-title":"Neurology"},{"key":"1556_CR8","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.105.533620","volume":"112","author":"AM Naidech","year":"2005","unstructured":"Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112:2851\u20136.","journal-title":"Circulation"},{"key":"1556_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1212\/01.wnl.0000342471.07290.07","volume":"72","author":"IA van der Bilt","year":"2009","unstructured":"van der Bilt IA, Hasan D, Vandertop WP, et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology. 2009;72:635\u201342.","journal-title":"Neurology"},{"key":"1556_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.677961","volume":"12","author":"F Lin","year":"2021","unstructured":"Lin F, Chen Y, He Q, et al. Prognostic value of elevated cardiac troponin I after aneurysmal subarachnoid hemorrhage. Front Neurol. 2021;12: 677961.","journal-title":"Front Neurol"},{"key":"1556_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/1099800417711584","volume":"19","author":"A McAteer","year":"2017","unstructured":"McAteer A, Hravnak M, Chang Y, et al. The relationships between BNP and neurocardiac injury severity, noninvasive cardiac output, and outcomes after aneurysmal subarachnoid hemorrhage. Biol Res Nurs. 2017;19:531\u20137.","journal-title":"Biol Res Nurs"},{"key":"1556_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13054-015-1181-5","volume":"20","author":"J Oras","year":"2016","unstructured":"Oras J, Grivans C, Bartley A, et al. Elevated high-sensitive troponin T on admission is an indicator of poor long-term outcome in patients with subarachnoid haemorrhage: a prospective observational study. Crit Care. 2016;20:11.","journal-title":"Crit Care"},{"key":"1556_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3171\/2013.8.JNS13625","volume":"120","author":"C Nyberg","year":"2014","unstructured":"Nyberg C, Karlsson T, Ronne-Engstr\u00f6m E. Predictors of increased cumulative serum levels of the N-terminal prohormone of brain natriuretic peptide 4 days after acute spontaneous subarachnoid hemorrhage. J Neurosurg. 2014;120:599\u2013604.","journal-title":"J Neurosurg"},{"key":"1556_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10143-018-1037-y","volume":"43","author":"R Jabbarli","year":"2020","unstructured":"Jabbarli R, Pierscianek D, Darkwah OM, et al. Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review. Neurosurg Rev. 2020;43:825\u201333.","journal-title":"Neurosurg Rev"},{"key":"1556_CR15","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618\u201351.","journal-title":"Circulation"},{"key":"1556_CR16","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/STROKEAHA.108.544700","volume":"40","author":"JA Frontera","year":"2009","unstructured":"Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition. Stroke. 2009;40:1963\u20138.","journal-title":"Stroke"},{"key":"1556_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","volume":"76","author":"M Shibuya","year":"1992","unstructured":"Shibuya M, Suzuki Y, Sugita K, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid haemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992;76:571\u20137.","journal-title":"J Neurosurg"},{"key":"1556_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2176\/nmc.51.679","volume":"51","author":"J Zhao","year":"2011","unstructured":"Zhao J, Zhou D, Guo J, et al. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo). 2011;51:679\u201383.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1556_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00701-003-0101-7","volume":"145","author":"GE Sviri","year":"2003","unstructured":"Sviri GE, Shik V, Raz B, et al. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir (Wien). 2003;145:851\u201360 (discussion 860).","journal-title":"Acta Neurochir (Wien)"},{"key":"1556_CR20","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1161\/01.STR.0000170699.59783.d6","volume":"36","author":"PP Tung","year":"2005","unstructured":"Tung PP, Olmsted E, Kopelnik A, et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke. 2005;36:1567\u20139.","journal-title":"Stroke"},{"key":"1556_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12028-011-9535-6","volume":"15","author":"PR Taub","year":"2011","unstructured":"Taub PR, Fields JD, Wu AH, et al. Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15:13\u20138.","journal-title":"Neurocrit Care"},{"key":"1556_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.107031","volume":"211","author":"G Kaur","year":"2021","unstructured":"Kaur G, Damodara N, Feldstein E, et al. Relation between brain natriuretic peptide and delayed cerebral ischemia in patients with aneurysmalsubarachnoid hemorrhage. Clin Neurol Neurosurg. 2021;211: 107031.","journal-title":"Clin Neurol Neurosurg"},{"key":"1556_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135.","journal-title":"Stroke"},{"key":"1556_CR24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","volume":"42","author":"MD Vergouwen","year":"2011","unstructured":"Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42:924\u20139.","journal-title":"Stroke"},{"key":"1556_CR25","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/STROKEAHA.111.646836","volume":"43","author":"R Dhar","year":"2012","unstructured":"Dhar R, Scalfani MT, Blackburn S, Zazulia AR, Videen T, Diringer M. Relationship between angiographic vasospasm and regional hypoperfusion in aneurysmal subarachnoid hemorrhage. Stroke. 2012;43:1788\u201394.","journal-title":"Stroke"},{"key":"1556_CR26","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","volume":"39","author":"RL Macdonald","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015\u201321.","journal-title":"Stroke"},{"key":"1556_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","volume":"10","author":"RL Macdonald","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10:618\u201325.","journal-title":"Lancet Neurol"},{"key":"1556_CR28","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.06.030","volume":"24","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wang Z, Qi S. Cardiac troponin elevation and outcome after subarachnoid hemorrhage: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2015;24:2375\u201384.","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01556-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-022-01556-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01556-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T22:52:15Z","timestamp":1676587935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-022-01556-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1007\/s12028-022-01556-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Study procedures followed the guidelines of the World Medical Association Declaration of Helsinki and were approved by the Ethics Committee of our institution. For this retrospective study, formal consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}}]}}